The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $93.27

Today's change-0.81 -0.86%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $93.27

Today's change-0.81 -0.86%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Endo International PLC down (U.S.)$0.81

Endo International PLC closed lower Friday, dropping (U.S.)$0.81 or 0.86% to (U.S.)$93.27. Over the last five days, shares are unchanged, but are currently 3.43% below its 52-week high. This security has outperformed the S&P 500 by 38.05% during the last year.

Key company metrics

  • Open(U.S.) $93.85
  • Previous close(U.S.) $94.08
  • High(U.S.) $94.17
  • Low(U.S.) $93.21
  • Bid / Ask-- / --
  • YTD % change+29.33%
  • Volume997,796
  • Average volume (10-day)1,505,827
  • Average volume (1-month)1,790,870
  • Average volume (3-month)2,993,081
  • 52-week range(U.S.) $57.14 to (U.S.) $96.58
  • Beta1.13
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward20.93×
  • Forward PEG2.36×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.32
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-25.16%

Endo International PLC has a net profit margin of -25.16%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue800764719595
Total other revenue--------
Total revenue800764719595
Gross profit376385373343
Total cost of revenue424379346252
Total operating expense8721,0986341,201
Selling / general / administrative192205172227
Research & development40314142
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)21548276681
Other operating expenses, total--------
Operating income-72-33485-607
Interest income (expense), net non-operating-61-62-53-54
Gain (loss) on sale of assets--------
Other--------
Income before tax-120-39139-654
Income after tax-57-25224-439
Income tax, total-63-13916-215
Net income-53-25221-437
Total adjustments to net income--------
Net income before extra. items-57-25224-442
Minority interest001-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-57-25224-442
Inc. avail. to common incl. extra. items-53-25221-437
Diluted net income-53-25221-437
Dilution adjustment0------
Diluted weighted average shares154153163128
Diluted EPS excluding extraordinary itemsvalue per share-0.37-1.640.15-3.45
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.580.430.470.00